Terms: = Bone cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
12 results:
1. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
[TBL] [Abstract] [Full Text] [Related]
2. pai-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
[TBL] [Abstract] [Full Text] [Related]
3. Impact of uPA/pai-1 and disseminated cytokeratin-positive cells in breast cancer.
Märkl B; Kazik M; Harbeck N; Jakubowicz E; Hoffmann R; Jung T; Steinfeld D; Schenkirsch G; Schlimok G; Oruzio D
BMC Cancer; 2019 Jul; 19(1):692. PubMed ID: 31307406
[TBL] [Abstract] [Full Text] [Related]
4. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via pai-1-Sox2 axis.
Zhang Y; Pan Y; Xie C; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
[TBL] [Abstract] [Full Text] [Related]
5. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract] [Full Text] [Related]
6. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
Galstian GM; Krechetova AV; Vasil'ev SA; Orel EB; Pustovoĭt LA; Egorova EO; Saridi EIu; Gemdzhian EG; Gorodetskiĭ VM
Anesteziol Reanimatol; 2012; (2):41-8. PubMed ID: 22834287
[TBL] [Abstract] [Full Text] [Related]
7. In vivo photoacoustic imaging of osteosarcoma in a rat model.
Hu J; Yu M; Ye F; Xing D
J Biomed Opt; 2011 Feb; 16(2):020503. PubMed ID: 21361659
[TBL] [Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract] [Full Text] [Related]
9. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive factors revisited.
Hayes DF
Breast; 2005 Dec; 14(6):493-9. PubMed ID: 16239111
[TBL] [Abstract] [Full Text] [Related]
11. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract] [Full Text] [Related]
12. Surgical treatment of tumor metastases: general considerations and results.
Schildberg FW; Meyer G; Piltz S; Koebe HG
Surg Today; 1995; 25(1):1-10. PubMed ID: 7538364
[TBL] [Abstract] [Full Text] [Related]
